A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee

Study Identifier
M10-889
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Osteoarthritis
  • Study Drug
  • ABT-652
  • Placebo
  • Naproxen
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    40 - 75 Years

    Protocol Summary

    To compare the analgesic efficacy and safety of ABT-652 administered twice daily (BID) to placebo in subjects with osteoarthritis (OA) of the knee.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 37220
    Chandler, Arizona, United States, 85224
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 37223
    Tempe, Arizona, United States, 85282
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 37215
    Tucson, Arizona, United States, 85704
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 37221
    Anaheim, California, United States, 92801
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 37222
    Burbank, California, United States, 91505
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 35956
    Chino, California, United States, 91710
    Status
    Not applicable
    Showing {first} - {last} of {total} Results